Minorities in Cancer Research Scientific Symposium
“Innovative molecular approaches and models to advance precision health equity”
AACR Virtual Annual Meeting 2021
Date: April 9, 2021
Live Panel Discussion, April 14, 2021, 3:30-4:00 p.m.
Co-Chairs:
- Sarki A. Abdulkadir, Northwestern University, Chicago, Illinois
- Luis Carvajal-Carmona, UC Davis Comprehensive Cancer Center School of Medicine, Davis, California
- Mariana C. Stern, USC Norris Comprehensive Cancer Center, Los Angeles, California
CME-Designated Session
In this session, nationally recognized scientists and emerging investigators will provide an update on the existing resources and methods that are being developed and applied to help minority populations access the benefits of precision health prevention and treatment. Precision medicine and cancer health disparity research are fields that have traditionally worked in silos. Recent efforts have been made by molecular- and population-based investigators to work together in the emerging field of precision health equity. To this end, the National Cancer Institute has fostered new initiatives to advance precision health equity by funding genomic studies and precision medicine centers that characterize tumors and models from minority patients.
Introduction
Luis Carvajal-Carmona, PhD, UC Davis, Davis, California
Genomic data resources and models for cancer health disparity research
Tiffany Wallace, PhD, National Cancer Institute, Bethesda, Maryland
Digital pathology applications in multiplex analysis and imaging
Kevin L. Gardner PhD Columbia University, New York, New York
Functional and pre-clinical studies in organoid models to advance our knowledge of gastric cancer biology and response to therapy
Nicole B. Coggins, PhD, UC Davis, Davis, California
Development and application of minority patient-derived xenografts to develop new cancer therapies
Nora M. Navone, MD, PhD, MD Anderson Cancer Center, Houston, Texas
Live Panel Discussion, April 14, 2021, 3:30-4:00 p.m Channel 08
Moderators: Committee Co-Chairs
Closing Remarks
Luis Carvajal-Carmona, PhD, UC Davis, Davis, California